在出现 COVID-19 大规模反弹的国家，不要再推迟提供加强针。
No further delays in offering booster doses in countries experiencing a major resurgence of COVID-19.
机构信息
Maladies Infectieuses, Université Paris-Saclay, AP-HP Hôpital Raymond Poincaré, Garches 92380, France.
Université Versailles-Saint-Quentin, Versailles F78180, France.
出版信息
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab187.
Abstract
Covid booster shots should be proposed and recommended to all fully vaccinated individuals, considering antibody levels are waning over time and that the risk of being infected typically reappears after 6 months.
摘要
应当向所有完全接种疫苗的人建议和推荐接种新冠加强针，因为抗体水平会随时间推移而下降，而且感染风险通常会在 6 个月后再次出现。
相似文献
1
No further delays in offering booster doses in countries experiencing a major resurgence of COVID-19.在出现 COVID-19 大规模反弹的国家，不要再推迟提供加强针。
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab187.
2
Why promoting a COVID-19 vaccine booster dose?为什么要推广新冠病毒疫苗加强针？
Anaesth Crit Care Pain Med. 2021 Dec;40(6):100967. doi: 10.1016/j.accpm.2021.100967.
3
Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations.在提供国内加强针疫苗接种之前先向其他国家供应疫苗。
JAMA. 2021 Sep 14;326(10):903-904. doi: 10.1001/jama.2021.13226.
4
COVID-19 vaccine equity and booster doses.新冠疫苗公平性与加强针
Lancet Infect Dis. 2021 Sep;21(9):1193. doi: 10.1016/S1473-3099(21)00486-2. Epub 2021 Aug 13.
5
A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.接种两剂新型冠状病毒灭活疫苗后，可能需要接种第三剂加强针以减轻中和抗体的衰减。
J Med Virol. 2022 Jan;94(1):35-38. doi: 10.1002/jmv.27334. Epub 2021 Sep 22.
6
SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen.两剂科兴疫苗接种方案后接种第三剂科兴疫苗或BNT162b2疫苗后的新冠病毒特异性抗体反应。
J Med Virol. 2022 Jan;94(1):39-41. doi: 10.1002/jmv.27350. Epub 2021 Sep 21.
7
Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.在系统性红斑狼疮患者中使用异源加强针后，康希诺新冠疫苗的免疫原性、安全性和反应原性：一项病例系列研究。
RMD Open. 2021 Dec;7(3). doi: 10.1136/rmdopen-2021-002019.
8
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.在先前感染过 SARS-CoV-2 的医护人员中，单次接种 ChAdOx1 nCoV-19 疫苗后的抗体反应。
EBioMedicine. 2021 Aug;70:103523. doi: 10.1016/j.ebiom.2021.103523. Epub 2021 Aug 12.
9
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis.在健康成年人中，SARS-CoV-2 变异 mRNA 疫苗加强针的安全性和免疫原性：一项中期分析。
Nat Med. 2021 Nov;27(11):2025-2031. doi: 10.1038/s41591-021-01527-y. Epub 2021 Sep 15.
10
2019 Novel Coronavirus Vaccination Among Medical Students.2019 年新型冠状病毒疫苗在医学生中的接种情况。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211058316. doi: 10.1177/21501327211058316.
引用本文的文献
1
Vaccine supply chain coordination using blockchain and artificial intelligence technologies.利用区块链和人工智能技术进行疫苗供应链协调。
Comput Ind Eng. 2023 Jan;175:108885. doi: 10.1016/j.cie.2022.108885. Epub 2022 Dec 5.
Zotero 插件